| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |